• Lead a team of seven program managers responsible for the day-to-day HUB operations of the BMS Access Support Program supporting 16 different brands within BMS’s Hematology and Oncology portfolio• Direct FRM LT on case resolution of program escalations and coach FRMs on how to discuss case escalations with provider sites as well as market access dynamics • One of only two home office representatives to be recognized in US Market Access as 2023 Presidents Club winner for outstanding performance• Work with BMS Market Access senior leadership to create an effective organizational model within Patient Access Support Services to optimize team structure and function. • Lead the development of market access strategies for launch brands and in-line products that inform on patient access, HUB program design and tactical executional for field reimbursement team• Inform US Market Access and Brand leadership on market access trends impacting patient access to BMS therapies and recommend appropriate mitigation strategies and patients support solutions • Meet with vendors in the market access and patient support space to assess innovative HUB solutions that will evolve BMS HUB services to provide a better customer experience while addressing patient access barriers • Strategic lead for the BMS PASS organization to assess market trends that could impact patient access as well as benchmarking of current HUB offerings and FRM models to evaluate performance vs competitors• Responsible for ~100m in OPEX and GTN budget

• Work closely with pricing, reimbursement & affordability, channel, and HEOR to develop strategic market access value proposition to support brand initiatives. • Develop strategic plans and utilize appropriate tools/ tactics to execute on disease education, healthcare economic data, and brand initiatives for payer, IDNs, and channel audiences• Leading strategy across all functional areas of VAP for Checkmate-9ER launch, including close collaboration with HEOR to develop healthcare economic data that supported the brand strategy • Worked with pricing team on oncology contracting strategy and was part of team that won 2020 peer leadership award for new OPDIVO and YEROVOY performance-based GPO contract• Lead creative agency management, status meetings, program schedules, and budgetary management• Manage medical, legal and regulatory review process for access materials

Create and deliver innovative market access strategies for the brand, supporting sales objectives by managing a best in class reimbursement and affordability program. Work with the Payer Marketing team to develop and execute patient access initiativesCreate and provide training to vendor partners on new indications, NCCN updates, business rules and market place trendsDirectly manage two Associate Program Managers who’s responsibility is to provide support in the development of reimbursement strategies and execution tacticsFacilitate improved vendor relationships in order to build better service offerings and patient experiencesExecute promotional pieces for access & reimbursement managersDevelop and manage the marketing strategy and operations of annual Re-verificationManage large cross functional matrix teams effectively in order to achieve business objectivesAppropriately manage A&P and GTN budgets

As part of the U.S. Value, Access & Payment organization, the ARM works closely across the matrix teams to support health care providers in obtaining appropriate access to BMS products for patients and is the subject matter expert for BMS Access Support services.•Drive awareness of BMS Access Support with Immuno-Oncology, Rheumatology, and Institutional customers as well as educate and provide solutions to access issues in order to decrease time-to-therapy for patients who are treated with BMS products.•Work closely with Account Executives and the BMS Access Support hub to identify regional & national reimbursement issues/concerns and ensure consistency with coding, coverage and payment with regional & national payers. •Deliver educational programs surrounding healthcare reform, specifically MACRA and the Oncology Care Model, to appropriate staff to inform them on how these laws affect the access and reimbursement environment. •Work with matrix team in identifying reimbursement obstacles and executing appropriate reimbursement solutions.•Provide home office approved reimbursement related training to District Manager and sales representatives within own geography. •Northeast Region point for our Rheumatology portfolio which includes, Orencia IV & Orencia SC formulations. The region point acts as a liaison between the field and home office providing the former with program updates and changes and the latter with process improvements based on customer feedback.

Developed reimbursement tactics to increase awareness of the reimbursement system Allergan has established and ensure patients have access to Botox therapeutic in a timely manner Responsible for the coordination and execution of Botox practice support for healthcare providers to help customers understand barriers that may impeded access to treatment for patients Worked closely with outside vendor on improving process for customer reimbursement support services Coordinated strategy, action planning, and reporting to address provider reimbursement needsSupported providers in developing and maintaining general practice management protocols for success in billing for injectable medications (Botox/Ozurdex)Interacted with key accounts to address past payment issues and discuss any concerns regarding reimbursementWorked in conjunction with payer-focused account management teams in defining various policies with government, commercial, and regional payers to impact patient’s access. Work closely with sales force to identify physician advocates who can positively influence payer decisions.

Develop and implement sales and business strategies to increase utilization of complex injectable neurotoxin for orphan indications within the movement disorder community. Establish trusting alliances with medical professionals including neurologists and physiatrists to launch commercial indication (Chronic Migraine) in 2010. Partner with Reimbursement Business Manager and Health Systems Manager, to implement cross functional training to customers and trainees. Played a key role in increasing district sales performance through mentoring and leadership; was crucial in the on-boarding of 6 new hires from 2010 – 2013 and provided support and assistance to colleagues to aid in product knowledge and territory management.Assisted Area Manager in conducting interviews for potential new hires. Field Sales Trainer: Worked closely with two new Manhattan NMCs to instruct them on the administrative duties required and conducted co-rides with them to help develop their professional selling skills. Field Input Team (2009-2010): Provided the marketing department with valuable feedback about how customers are responding to new marketing tools and messages.Led several regional conference calls to improve region productivity and efficiency. Topics included Chronic Migraine injection paradigm, ULS Sales Tools, Sales Operations Process , and the role of the RBM. Led region presentations at National Sales Meetings and POA meetings.

Launched Ranexa in 2006 for the angina marketplace to high volume interventional cardiologists. Focused on hospital formulary wins and discharge orders. Ranked 30th out of 250 for Ranexa launch in 2006 and finished in the top 25% of the company for Ranexa sales in 2006.

Responsible for promoting and growing market share of Lexapro, Namenda, Tiazac, Aerobid and Benicar to neurology, psychiatry and primary care. Consistently ranked in top 30% of peers out of 530 territories nationally. Sales Rep of the quarter for Q2 2003, Q3 2003, and Q1 2004. One of 40 chosen to be promoted to field sales trainer for NJ Division in 03, 04, and 05